Abemaciclib 150mg Tablets

Abemaciclib 150mg is a CDK4/6 inhibitor for selected hormone-receptor-positive, HER2-negative breast cancers. It may be combined with endocrine treatment in early high-risk or advanced disease, or used alone in an appropriate previously treated setting.
Swallow the tablet whole with water at the scheduled morning and evening times, with or without food. Do not split, crush or chew. Avoid grapefruit.
Abemaciclib inhibits cyclin-dependent kinases 4 and 6, interrupting the cell-cycle signals that allow hormone-responsive breast-cancer cells to divide.
Diarrhoea, nausea, fatigue, low white-cell counts, anaemia and reduced appetite can occur. Blood clots, liver injury and interstitial lung disease are important serious risks.
Start the supplied anti-diarrhoeal treatment at the first loose stool and replace fluids. Blood counts and liver tests are monitored. Report unilateral leg swelling, chest pain, fever or new breathlessness promptly.
Adding cell-cycle inhibition to a suitable endocrine regimen can reduce recurrence risk or delay progression, depending on the disease setting.
No. It blocks cell-cycle kinases, while an aromatase inhibitor reduces oestrogen production. Their complementary actions explain why they may be combined.
Diarrhoea often starts in the first week and can lead to dehydration. Persistent or severe symptoms may require a treatment interruption or dose reduction.
Skip that dose and take the next one at its usual scheduled time. Do not take another tablet after vomiting or double a later dose to catch up.
Abemaciclib can reduce tubular creatinine secretion. Other kidney-function measures may help distinguish this effect from kidney injury.
CDK4/6: enzymes that regulate cell-cycle progression. HR-positive: cancer expressing hormone receptors. Endocrine therapy: treatment that reduces hormone stimulation of a tumour.; AR: Abemaciclib 150mg أقراص; FR: Abemaciclib 150mg comprimés; PT: Abemaciclib 150mg comprimidos; ES: Abemaciclib 150mg comprimidos; RU: Abemaciclib 150mg таблетки; ID: Abemaciclib 150mg tablet; VI: Abemaciclib 150mg viên nén; MS: Abemaciclib 150mg tablet; TL: Abemaciclib 150mg mga tableta; ZH-SG: Abemaciclib 150mg 片剂
International B2B Enquiry
Send a structured B2B enquiry for Abemaciclib 150mg Tablets under Oncology Care. Global Medicines Export helps international buyers review product information, pack details, quantity requirements, destination-market needs, quotation support and export documentation coordination from India.
Product name, required strength or pack, expected quantity, destination country, buyer type and preferred manufacturer if any.
Availability, quotation support, documentation expectations and shipment-ready order communication can be reviewed before confirmation.
Commercial invoice, packing information, manufacturer details, batch details and supporting documents where applicable and available.
Product availability, quotation, and documentation support are coordinated for international B2B enquiries.
Abemaciclib 150mg Tablets